The Science of Us
Depression doesn't always hit like a thunderbolt; for many of the 280 million people affected globally, it feels like a creeping fog or wading through wet cement. This episode deconstructs the long-held "chemical imbalance" theory, exploring why the standard fix of SSRIs often falls short—taking weeks to work or failing to help two-thirds of patients entirely. We dive into the modern neuroscience of the HPA axis, revealing how chronic stress acts as a "corrosive" force that physically damages synaptic connections in the brain. By examining the "Number Needed to Treat" , we uncover a startling statistical reality: while it takes seven patients on antidepressants for one to see a benefit beyond a placebo, exercise boasts a dramatically superior NNT of just 2. We trace the evolution of exercise from an accidental discovery in a 1980s cardiovascular study to its current status as a "targeted pharmacology" that strikes depression at its structural roots. Discover the results of the landmark SMILE trial, which found that while drugs and exercise are equally effective in the short term, the relapse rate for exercise-only patients was just 8% compared to 38% for those on medication. Unlike a passive pill, physical activity builds a durable sense of self-efficacy and mastery. Whether it’s a 30-minute jog or a yoga class, learn why movement is emerging as a safer, cheaper, and more efficient intervention for the world’s leading cause of disability.
16 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Science of Us!